(Q39383671)

English

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

scientific article

Statements

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome (English)
0 references
0 references
1 February 2004
119-126

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit